Wilson, Latham Tapped for $208 Million Biotech Deal

, The Recorder

   | 0 Comments

SAN FRANCISCO — Attorneys from Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised on genomics technology firm Fluidigm Corp.'s $208 million acquisition of DVS Sciences Inc., which makes a device used to analyze single cells in biological research.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202640657194

Thank you!

This article's comments will be reviewed.